GenToX Nominated for Buzz of BIO Award for the Technology of Tomorrow Category

The Award is hosted by Biotechnology Industry Organization at the 2015 BIO International Convention.

King of Prussia, PA, April 18, 2015 –(PR.com)– GenToX has been nominated for the Buzz of BIO Awards in the Technology of Tomorrow category being announced at the 2015 BIO International Convention. Hosted by the Biotechnology Industry Organization (BIO), the 2015 BIO International Convention will take place June 15-18 at the Pennsylvania Convention Center in Philadelphia, Pennsylvania. During the Buzz of BIO contest, industry leaders will be voting for companies they would like to see present at the conference. The community voting period begins at 9:00:00 AM ET on April 14, 2015 and ends at 5:00:00 PM ET on April 21, 2015 at: http://convention.bio.org/buzzofbio/

“We are so honored to have been nominated for this honor at an international convention like this right in our neighborhood,” said GenToX CEO, Matthew Bennett.
“We’ve known for awhile about the value of pharmacogenomic testing but to be recognized amongst industry leaders and our esteemed peers is extremely exciting for us.”

GenToX is a pharmacogenomic and toxicology testing company based in Pennsylvania with the mission of helping the medical community provide personalized care for patients worldwide. Pharmacogenomic testing analyzes a patient’s DNA to identify gene variations that affect a person’s inability to metabolize certain medications in the areas of pain management, cardiology, and psychiatric care to name a few.

About The BIO International Convention
The annual BIO International Convention is the largest global event for the biotechnology industry. The Convention attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.

Background on GenToX, Inc.
GenToX™ is a pharmacogenomic and toxicology testing company located in King of Prussia, PA. Our pharmacogenomic testing analyzes a patient’s DNA and the results help guide doctors on how well a patient metabolizes certain medications, providing personalized medical care. All of our tests come with a comprehensive report for any doctor, hospital, nursing home or healthcare plan. For more information about testing in your area, visit http://www.gentoxtesting.com

Contact: info@gentoxtesting.com
610-291-7417
Contact Information
Gentox
Matt Bennett
610-291-7417
Contact
www.gentoxtesting.com